Intended for healthcare professionals


Women still not being told about pregnancy risks of valproate

BMJ 2017; 358 doi: (Published 22 September 2017) Cite this as: BMJ 2017;358:j4426
  1. Jacqui Wise
  1. London

Two thirds of women who take the antiepileptic drug sodium valproate said they had not received new safety warnings about the dangers of taking it during pregnancy, a survey carried out by epilepsy charities has found. A similar survey last year found that half of women taking the drug were unaware it could harm their fetus.1

The new results are to be presented at a public hearing on the safety of valproate drugs organised by the European Medicines Agency on 26 September in London. This is the first time that the EMA has held a public hearing as part of the safety review of a drug, and it will …

View Full Text

Log in

Log in through your institution


* For online subscription